Breast Cancer Trials 43rd Annual Scientific Meeting
27 July, 2022 - 29 July, 2022
Breast Cancer Trials (BCT) is a world-leading clinical trials research organisation, dedicated to finding new and better treatments and prevention strategies for people affected by this disease. BCT’s research program involves multicentre national and international clinical trials and brings together more than 820 researchers in 109 institutions throughout Australia and New Zealand. BCT has contributed to almost 1200 peer reviewed publications and more than 16,300 women have participated in our breast cancer clinical trials.
The theme for the 2022 Annual Scientific Meeting (ASM) is breast cancer in young women, with a number of key presentations on this important topic. The ASM will also host a number of internationally renowned guest speakers including key BCT researchers. Delegates include leading Australian and New Zealand medical practitioners and clinicians, and clinical trials management personnel. The full and extensive program will include two days of scientific sessions covering timely reviews of breast cancer clinical trials, discussion of new protocols, future clinical trials research and other research developments.